Recent Updates
Recently added Catalysts
ORIC Positive Sentiment

ORIC Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

Tuesday, January 3, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: ORIC Pharmaceuticals, a clinical-stage oncology company, announced that CEO Jacob M. Chacko will present an overview of the company at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023. This presentation will focus on ORIC's efforts in developing treatments to tackle therapeutic resistance in oncology. The event represents a significant opportunity for the company to connect with investors and communicate its strategic vision.
Price reaction · baseline $5.89 (2022-12-30 close) · hit after-hours · clean, no other ORIC news in the window
day 0 close · peak
+1.7%

Market Sentiment Analysis

POSITIVE FACTORS

  • ORIC Pharmaceuticals is actively engaging with investors through a prominent conference.
  • The presentation highlights the company's commitment to developing treatments for therapeutic resistance.
  • The event is a strategic platform for showcasing ORIC's advancements and attracting potential investments.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+58%
120-day peak, hindsight
Typical move
10.1%
average across 6 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
ORIC-944
Phase 1 · Metastatic Prostate Cancer

Full Press Release Details

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 03, 2023 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob M. Chacko, M.D., chief executive officer, will present a company overview at the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 11:15 a.m. PT.
A live webcast of the company presentation will be available through the investor section of the company’s website at www.oricpharma.com. A replay of the webcast will be available for 90 days following the event.
About ORIC Pharmaceuticals, Inc.

Frequently Asked Questions

When is ORIC Pharmaceuticals' presentation at the J.P. Morgan Conference?

The presentation is on January 10, 2023, at 11:15 a.m. PT.

Who will present ORIC's company overview?

Jacob M. Chacko, M.D., the CEO, will present the overview.

Where can I watch the ORIC Pharmaceuticals presentation?

It will be available on ORIC Pharmaceuticals' website in the investor section.

How long will the webcast replay be available?

The replay will be accessible for 90 days after the event.

Who is the CFO of ORIC Pharmaceuticals?

Dominic Piscitelli is the Chief Financial Officer.

ShareAdd on Google
Tags: ORIC Viatris Investor Conferences Healthcare ORIC Pharmaceuticals oncology therapeutic resistance J.P. Morgan investors
Last updated: Jan 3, 2023

Biotech snapshot

Cash runway
$388M liquidity · $11M/mo burn
~36 mo
Minimal dilution risk
Lead asset
ORIC-944Phase 1
Metastatic Prostate Cancer →

Catalyst track record

+58%
best trade around ORIC's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for ORIC.

See every catalyst's timing & PoA →